CNPY3 Human

Canopy 3 Homolog Human Recombinant
Shipped with Ice Packs
In Stock

Description

Immune System Regulation

CNPY3 ensures proper folding of TLRs (TLR1, TLR2, TLR4, TLR7-9) via HSP90B1, enabling their transport from the ER to cell membranes or endosomes . This process is vital for:

  • Innate immune responses to pathogens .

  • Adaptive immunity through dendritic cell and B-cell activation .

  • Antiviral defense via TLR-mediated interferon production .

Neurological Development

CNPY3 deficiency causes severe neurodevelopmental disorders:

  • West syndrome: Biallelic CNPY3 variants (e.g., c.373G>C, c.702_720dup) lead to hippocampal malrotation, epileptic spasms, and hypsarrhythmia .

  • Mouse models: Cnpy3 −/− mice exhibit hyperactivity, anxiolytic behavior, and abnormal EEG fast-beta waves (20–35 Hz) .

Genetic Disorders

ConditionVariant TypeClinical FeaturesMechanism
West syndromeBiallelic missense/LOFEpileptic spasms, developmental delayImpaired TLR folding, neuronal excitability
Hippocampal malrotationHomozygous splicingBrain atrophy, spastic quadriplegiaER stress, disrupted neuronal migration

Cancer

  • Colon adenocarcinoma: CNPY3 upregulation correlates with advanced TNM stages, poor survival, and PI3K/AKT pathway activation. Knockdown reduces proliferation and metastasis .

  • Therapeutic target: Lipid nanoparticles (LNPs) delivering CNPY3 mRNA suppress flavivirus replication (e.g., Zika, dengue) by restoring TLR-mediated interferon responses .

  • Antiviral therapy: LNP-CNPY3 restores interferon signaling in flavivirus-infected mice, improving survival and reducing neuroinflammation .

  • Cancer immunotherapy: CNPY3 inhibition sensitizes tumors to immune checkpoint blockers by altering stromal and immune scores .

Product Specs

Introduction
Canopy 3 homolog (CNPY3) is a 271 amino acid long Toll-like receptor specific co-chaperone for HSP90B1. It is essential for the proper folding of most Toll-like receptors, except TLR3, and regulates their exit from the endoplasmic reticulum. This makes CNPY3 crucial for both innate and adaptive immune responses.
Description
Recombinant human CNPY3 protein was produced in E. coli. It is a single, non-glycosylated polypeptide chain comprising 271 amino acids (residues 31-278) with a molecular weight of 29.9 kDa. The protein includes a 23 amino acid His-tag at the N-terminus and has been purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The CNPY3 protein solution is provided at a concentration of 0.5 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the protein at -20°C. Adding a carrier protein such as HSA or BSA (0.1%) is advisable for extended storage durations. Avoid repeated freezing and thawing of the product.
Purity
The purity of the CNPY3 protein is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
CAG4A, ERDA5, PRAT4A, TNRC5, Protein canopy homolog 3, CTG repeat protein 4a, Expanded repeat-domain protein CAG/CTG 5, Protein associated with TLR4, Trinucleotide repeat-containing gene 5 protein,CNPY3.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSGPSQAGA EENDWVRLPS KCEVCKYVAV ELKSAFEETG KTKEVIGTGY GILDQKASGV KYTKSDLRLI EVTETICKRL LDYSLHKERT GSNRFAKGMS ETFETLHNLV HKGVKVVMDI PYELWNETSA EVADLKKQCD VLVEEFEEVI EDWYRNHQEE DLTEFLCANH VLKGKDTSCL AEQWSGKKGD TAALGGKKSK KKSSRAKAAG GRSSSSKQRK ELGGLEGDPS PEEDEGIQKA SPLTHSPPDE L.

Product Science Overview

Structure and Characteristics

CNPY3 is a 271 amino acid protein with a molecular mass of approximately 29.9 kDa. It is produced as a single, non-glycosylated polypeptide chain in Escherichia coli (E. coli) and is often fused to a 23 amino acid His-tag at the N-terminus for purification purposes . The protein solution typically contains 20 mM Tris-HCl buffer (pH 8.0), 0.15 M NaCl, 10% glycerol, and 1 mM DTT .

Function

CNPY3 functions as a co-chaperone for HSP90B1, a heat shock protein. It is specifically required for the proper folding of Toll-like receptors, excluding TLR3, and controls their exit from the endoplasmic reticulum . This process is vital for the immune system’s ability to recognize and respond to pathogens.

Biological Significance

The role of CNPY3 in the immune system is significant due to its involvement in the folding and export of TLRs. TLRs are a class of proteins that play a key role in the innate immune system by recognizing pathogen-associated molecular patterns (PAMPs) and initiating immune responses . Without proper folding and functioning of TLRs, the immune system’s ability to detect and respond to infections would be compromised.

Clinical Relevance

Mutations or dysregulation of the CNPY3 gene have been associated with various immune-related disorders. For instance, CNPY3 is linked to Developmental and Epileptic Encephalopathy 60 and West Syndrome . These associations highlight the importance of CNPY3 in maintaining immune system homeostasis and its potential as a therapeutic target.

Research and Applications

Recombinant CNPY3 is widely used in research to study its role in TLR folding and immune responses. It is also utilized in various assays and experiments to understand its interactions with other proteins and its impact on immune signaling pathways .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.